biguanides has been researched along with Hyperlipoproteinemia in 2 studies
Biguanides: Derivatives of biguanide (the structure formula HN(C(NH)NH2)2) that are primarily used as oral HYPOGLYCEMIC AGENTS for the treatment of DIABETES MELLITUS, TYPE 2 and PREDIABETES.
biguanides : A class of oral hypoglycemic drugs used for diabetes mellitus or prediabetes treatment. They have a structure based on the 2-carbamimidoylguanidine skeleton.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pados, G | 1 |
| Padosh, D | 1 |
| Kustosh, D | 1 |
| Puchok, I | 1 |
| Dem'ianova, N | 1 |
| Audikovski, M | 1 |
1 trial available for biguanides and Hyperlipoproteinemia
| Article | Year |
|---|---|
[Adverse effect of butylbiguanide therapy on alpha-lipoprotein cholesterol levels].
Topics: Biguanides; Buformin; Cholesterol; Clinical Trials as Topic; Humans; Hyperlipoproteinemias; Lipoprot | 1980 |
1 other study available for biguanides and Hyperlipoproteinemia
| Article | Year |
|---|---|
[Effect of diet and drug therapy on the level of high density lipoprotein cholesterol in patients with primary hyperlipoproteinemia].
Topics: Biguanides; Cholesterol; Cholesterol, HDL; Clofibrate; Dietary Fats; Humans; Hyperlipoproteinemias; | 1981 |